By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tigris Pharmaceuticals 

3359 Woods Edge Circle
Suite 103
Bonita Springs  Florida  34134  U.S.A.
Phone: 239-444-5400 Fax: 321-206-8627



Company News
Tigris Pharmaceuticals Initiates Randomized Phase 2 Study of AFP-464 in ER-Positive Breast Cancer Patients 5/26/2011 4:59:34 PM
Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive Chairman of the Board 9/29/2010 8:15:51 AM
Tigris Pharmaceuticals Completes $6.5 Million Private Placement 9/29/2010 8:10:59 AM
First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418 5/1/2009 12:03:24 PM
Tigris Pharmaceuticals Presents Results of Breast Cancer Research at American Association for Cancer Research Annual Meeting 4/30/2009 9:46:19 AM
Tigris Pharmaceuticals Appoints Pedro Granadillo as Chairman of Board of Directors 4/16/2009 9:49:17 AM
FDA Accepts Investigational New Drug (IND) Application for Tigris Pharmaceuticals's GGTI-2418 3/4/2009 8:37:51 AM
Tigris Pharmaceuticals Files IND Application for GGTI-2418 2/6/2009 8:35:35 AM
Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 5/15/2008 8:08:53 AM
Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors 1/31/2008 9:55:27 AM